From e-health records to a biotech hub in Tartu, Estonia is harnessing data, digital infrastructure, and investment to drive ...

The toilet separates liquids from solids, with the solid waste going into a mycelium-lined compartment, where lab tests have ...

From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

In this second installment of the series, we talk to South African sinologist Paul TEMBE, who, after two decades of ...

Q3 2025 Earnings Call November 13, 2025 11:00 AM ESTCompany ParticipantsTorben Teichler - CFO, Chief Investment Officer & ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Q3 2025 Earnings Call November 13, 2025 9:00 AM ESTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid ...

UKCEH hosted the 10th Cumbrian Lakes Research Forum on the shores of Windermere early this November. The week’s heavy rain ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

The nation’s busiest transit hub stands as a symbol of a condition that afflicts so many attempts to get big things done in America: inertia.